Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 2/14/2017
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||K010050 / -||UN / UN|
Administered by: Other Purchased by: Other
Symptoms: Abdominal pain, Bone pain, Chronic fatigue syndrome, Headache, Hepatic pain, Injection site pain, Memory impairment, Muscular weakness, Myalgia, Pain, Palpitations, Paraesthesia, Renal pain, Visual impairment, Postural orthostatic tachycardia syndrome, Spinal pain, Loss of personal independence in daily activities
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? Yes
Hospitalized? Yes, days: 3
Write-up:Information has been received from Sanofi Pasteur MSD (manufacturer control number # 2016007569) as part of business agreement on 26-JUL-2016. This case was received from the RA on 21-Jul-2016 under reference numbers GB-MHRA-ADR 23560715/ GB-MHRA-EYC 00142401. Case received from a consumer/other non health professional on 21-Jul-2016. A 13-year-old female adolescent patient received GARDASIL (lot/batch number K010050) via parenteral route on 05-May-2016. The patient received concomitant administration of Chelidonium Extract on an unknown date, Hawthorn/01349301/) on a unknown date, ibuprofen on an unknown date, MERLICON on an unknown date, ''Milk thistle seed'' on an unknown date, Multivitamin/0097801/) on an unknown date, Paracetamol on an unknown date, Penicillin/00000901/) on an unknown date. On 12-May-2016, 7 days post administration, the patient experienced postural orthostatic tachycardia syndrome, visual disturbance, frontal headache, occipital headache, chronic fatigue syndrome, spleen pain, liver pain, kidney pain, pelvic bone pain, spinal pain, Injection site muscle pain, Forearm muscle pain, generalized muscle weakness, paraesthesia, trigger point pain, palpitations and memory impaired. The patient was unable to commit to normal day to day activities. The patient''s symptoms worsened daily and pain was increased to a point where she was admitted to hospital 3 nights. The patient''s outcome was reported as not recovered/not resolved. Postural orthostatic tachycardia syndrome; visual disturbance, frontal headache; occipital headache; chronic fatigue syndrome; spleen pain; liver pain; kidney pain; pelvic bone pain; spinal pain; injection site muscle pain; forearm muscle pain; generalized muscle weakness; paraesthesia; trigger point pain; palpitations and memory impaired. Unable to commit to normal day to day activities. Symptoms worsened daily. Pain increased to a point where she was admitted to hospital for 3 nights.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166